Related references
Note: Only part of the references are listed.Effect of COVID-19 on smoking cessation outcomes in a large primary care treatment programme: an observational study
Scott Veldhuizen et al.
BMJ OPEN (2021)
Measures of Effectiveness, Efficiency, and Quality of Telemedicine in the Management of Alcohol Abuse, Addiction, and Rehabilitation: Systematic Review
Clemens Scott Kruse et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2020)
Tobacco smoking and COVID-19 infection
Richard N. van Zyl-Smit et al.
LANCET RESPIRATORY MEDICINE (2020)
Smoking and COVID-19: Adding Fuel to the Flame
Vivek K. Kashyap et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Remote Methods for Conducting Tobacco-Focused Clinical Trials
Jennifer Dahne et al.
NICOTINE & TOBACCO RESEARCH (2020)
Varenicline and Bupropion for Long-Term Smoking Cessation (the MATCH Study): Protocol for a Real-World, Pragmatic, Randomized Controlled Trial
Laurie Zawertailo et al.
JMIR RESEARCH PROTOCOLS (2018)
Is it cost-effective to provide internet-based interventions to complement the current provision of smoking cessation services in the Netherlands? An analysis based on the EQUIPTMOD
Kei-Long Cheung et al.
ADDICTION (2018)
Effectiveness of additional follow-up telephone counseling in a smoking cessation clinic in Beijing and predictors of quitting among Chinese male smokers
Lei Wu et al.
BMC PUBLIC HEALTH (2016)
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
Robert M. Anthenelli et al.
LANCET (2016)
Comparative Effectiveness of an Internet-Based Smoking Cessation Intervention Versus Clinic-Based Specialty Care for Veterans
Patrick S. Calhoun et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2016)
Systematic review and meta-analysis of Internet interventions for smoking cessation among adults
Amanda L. Graham et al.
SUBSTANCE ABUSE AND REHABILITATION (2016)
Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development
Robert West et al.
ADDICTION (2015)
Empowering smokers with a web-assisted tobacco intervention to use prescription smoking cessation medications: a feasibility trial
Peter Selby et al.
IMPLEMENTATION SCIENCE (2015)
Biochemical Validation of Self-Reported Smokeless Tobacco Abstinence among Smokeless Tobacco Users: Results from a Clinical Trial of Varenicline in India
Raka Jain et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2015)
Internet-based interventions for smoking cessation
Marta Civljak et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
Franz Faul et al.
BEHAVIOR RESEARCH METHODS (2007)
Antidepressants for smoking cessation
J. R. Hughes et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
Smoking cessation with varenicline, a selective α4β2 nicotinic receptor partial agonist -: Results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up
Mitchell Nides et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation -: A randomized controlled trial
David Gonzales et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation -: A randomized controlled trial
Douglas E. Jorenby et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Effectiveness of interventions to help people stop smoking:: findings from the Cochrane Library
T Lancaster et al.
BRITISH MEDICAL JOURNAL (2000)
Share Paper
